Pharmaceutical Research

, Volume 17, Issue 11, pp 1408–1413 | Cite as

In Vivo Study of the Effect of Valpromide and Valnoctamide in the Pilocarpine Rat Model of Focal Epilepsy

  • Hilde Lindekens
  • Ilse Smolders
  • Ghous M Khan
  • Meir Bialer
  • Guy Ebinger
  • Yvette Michotte


Purpose. We evaluated the effectiveness of the commonly used antiepileptic drug sodium valproate (400 mg/kg) and two of its amide derivatives, valpromide and valnoctamide (both 100 mg/kg), in an in vivo rat model of focal epilepsy. Our main interest was to get insight into possible changes in extracellular amino acid neurotransmitter levels following administration of the drugs, both in control and in epileptic conditions.

Methods. Seizures were evoked in freely moving rats by intrahippocampal administration of pilocarpine via a microdialysis probe (10 mM for 40 min at 2 μl/min). Microdialysis was also used as in vivo sampling technique and alterations in extracellular hippocampal glutamate and GABA levels were monitored. Electrophysiological evidence for the presence or absence of seizures was simultaneously recorded with electrocorticography.

Results. The focally evoked pilocarpine-induced seizures were completely prevented by acute intraperitoneal pretreatment with each of the three drugs in the respective doses. Effective protection was reflected in the electrocorticographic recordings and in the lack of sustained elevations of the extracellular glutamate levels after pilocarpine perfusion. Little effects were seen on the basal extracellular amino acid levels after systemic administration of each of the compounds, nor after the intrahippocampal administration of sodium valproate.

Conclusions. Valnoctamide and valpromide (100 mg/kg) proved to be at least as effective as their parent compound sodium valproate (400 mg/kg) against pilocarpine-induced seizures. All three compounds however failed to induce significant initial alterations in extracellular hippocampal GABA release. This questions the enhancement of GABA-mediated inhibition as being one of their mechanisms of action.

sodium valproate valnoctamide valpromide GABA glutamate pilocarpine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M. Bialer, A. Haj-Yehia, K. Badir, and S. Hadad. Review: Can we develop improved derivatives of valproic acid? Pharmacy World & Science 16:2-6 (1994).Google Scholar
  2. 2.
    M. A. Rogawski and R. J. Porter. Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42: 223-286 (1990).Google Scholar
  3. 3.
    R. L. Macdonald and K. M. Kelly. Antiepileptic drug mechanisms of action. Epilepsia 34(Suppl. 5):S1-S8 (1993).Google Scholar
  4. 4.
    W. Löscher. Valproate: A reappraisal of its pharmacodynamic properties and mechanisms of action. Prog. Neurobiol. 58:31-59 (1999).Google Scholar
  5. 5.
    M. Radatz, K. Ehlers, B. Yagen, M. Bialer, and H. Nau. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid. Epilepsy Res. 30:41-48 (1998).Google Scholar
  6. 6.
    W. Löscher and H. Nau. Pharmacological evaluation of various metabolites and analogues of valproic acid. Anticonvulsant and toxic potencies in mice. Neuropharmacology 24:427-435 (1985).Google Scholar
  7. 7.
    S. Blotnik, F. Bergman, and M. Bialer. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats. Drug Metab. Disp. 24:560-564 (1996).Google Scholar
  8. 8.
    W. A. Turski, E. A. Cavalheiro, C. Coimbra, M. Berzaghi, C. Ikonomidou-Turski, and L. Turski. Only certain antiepileptic drugs prevent seizures induced by pilocarpine. Brain Res. Rev. 12:281-305 (1987).Google Scholar
  9. 9.
    I. Smolders, G. M. Khan, J. Manil, G. Ebinger, and Y. Michotte. NMDA receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats by microdialysis. Br. J. Pharmacol. 121:1171-1179 (1997).Google Scholar
  10. 10.
    J. P. Leite and E. A. Cavalheiro. Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res. 20:93-104 (1995).Google Scholar
  11. 11.
    G. Paxinos and C. Watson. The Rat Brain in Stereotaxic Coordinates, 2nd edition, Academic Press Inc., San Diego, 1986.Google Scholar
  12. 12.
    I. Smolders, S. Sarre, Y. Michotte, and G. Ebinger. The analysis of excitatory, inhibitory and other amino acids in rat brain microdialysates using microbore liquid chromatography. J. Neurosci. Meth. 57:47-53 (1995).Google Scholar
  13. 13.
    M. Isokawa and L. E. Mello. NMDA receptor-mediated excitability in dendritically deformed dentate granule cells in pilocarpine-treated rats. Neurosci. Lett. 129:69-73 (1991).Google Scholar
  14. 14.
    L. E. Mello, E. A. Cavalheiro, A. M. Tan, W. R. Kupfer, J. K. Pretorius, T. L. Babb and D. Finch. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: Cell loss and mossy fiber sprouting. Epilepsia 34:985-995 (1993).Google Scholar
  15. 15.
    M. Marchi, P. Bocchieri, L. Garbarino, and M. Raiteri. Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes. Neurosci. Lett. 96:229-234 (1989).Google Scholar
  16. 16.
    R. J. Valentino and R. Dingledine. Presynaptic inhibitory effect of acetylcholine in the hippocampus. J. Neurosci. 1:784-792 (1981).Google Scholar
  17. 17.
    I. Smolders, K. Van Belle, G. Ebinger, and Y. Michotte. Hippocampal and cerebellar extracellular amino acids during pilocarpine-induced seizures in freely moving rats. Eur. J. Pharmacol. 319:21-29 (1997).Google Scholar
  18. 18.
    I. Smolders, G. M. Khan, H. Lindekens, S. Prikken, C. A. Marvin, J. Manil, G. Ebinger, and Y. Michotte. Effectiveness of vigabatrin against focally evoked pilocarpine-induced seizures and concomitant changes in extracellular hippocampal and cerebellar glutamate, GABA and dopamine levels, a microdialysis-electrocorticography study in freely moving rats. J. Pharmacol. Exp. Ther. 283:1239-1248 (1997).Google Scholar
  19. 19.
    C. S. Biggs, B. R. Pearce, L. J. Fowler, and P. S. Whitton. The effect of sodium valproate on extracellular GABA and other amino acids in the rat ventral hippocampus: An in vivo microdialysis study. Brain Res. 594:138-142 (1992).Google Scholar
  20. 20.
    V. Armand, J. Louvel, R. Pumain, and U. Heinemann. Effects of new valproate derivatives on epileptiform discharges induced by pentylenetetrazole or low Mg2+ in rat entorhinal cortex-hippocampus slices. Epilepsy Res. 32:345-355 (1998).Google Scholar

Copyright information

© Plenum Publishing Corporation 2000

Authors and Affiliations

  • Hilde Lindekens
    • 1
  • Ilse Smolders
    • 1
  • Ghous M Khan
    • 1
  • Meir Bialer
    • 2
  • Guy Ebinger
    • 3
  • Yvette Michotte
    • 4
  1. 1.Department of Pharmaceutical Chemistry and Drug analysisVrije Universiteit BrusselBrusselsBelgium
  2. 2.Department of Pharmaceutics, Faculty of MedicineThe Hebrew UniversityJerusalemIsrael
  3. 3.Department of NeurologyUniversity HospitalBrusselsBelgium
  4. 4.Department of Pharmaceutical Chemistry and Drug analysisVrije Universiteit BrusselBrusselsBelgium

Personalised recommendations